Use of recombinant factor VIIa in a preterm infant with coagulopathy and subdural hematoma

Emel Altuncu, Su Berrak, Hülya Bilgen, Ziya Yurdakul, Cengiz Canpolat, Eren Özek

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Activated recombinant factor VIIa was administered to a preterm infant with bleeding diasthesis and a huge subdural hematoma that could not be controlled by the blood products. The coagulation tests were normalized the following day. Recombinant factor VIIa can be a choice in selected cases with intractable bleedings unesponsive to conventional replacement therapy.

Original languageEnglish (US)
Pages (from-to)627-629
Number of pages3
JournalJournal of Maternal-Fetal and Neonatal Medicine
Volume20
Issue number8
DOIs
StatePublished - 2007
Externally publishedYes

Fingerprint

Subdural Hematoma
Premature Infants
Hemorrhage
recombinant FVIIa
Therapeutics

Keywords

  • Bleeding diasthesis
  • Factor VIIa
  • Preterm

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Obstetrics and Gynecology

Cite this

Use of recombinant factor VIIa in a preterm infant with coagulopathy and subdural hematoma. / Altuncu, Emel; Berrak, Su; Bilgen, Hülya; Yurdakul, Ziya; Canpolat, Cengiz; Özek, Eren.

In: Journal of Maternal-Fetal and Neonatal Medicine, Vol. 20, No. 8, 2007, p. 627-629.

Research output: Contribution to journalArticle

Altuncu, Emel ; Berrak, Su ; Bilgen, Hülya ; Yurdakul, Ziya ; Canpolat, Cengiz ; Özek, Eren. / Use of recombinant factor VIIa in a preterm infant with coagulopathy and subdural hematoma. In: Journal of Maternal-Fetal and Neonatal Medicine. 2007 ; Vol. 20, No. 8. pp. 627-629.
@article{54ade87bcded488580f9de4bf94b97ab,
title = "Use of recombinant factor VIIa in a preterm infant with coagulopathy and subdural hematoma",
abstract = "Activated recombinant factor VIIa was administered to a preterm infant with bleeding diasthesis and a huge subdural hematoma that could not be controlled by the blood products. The coagulation tests were normalized the following day. Recombinant factor VIIa can be a choice in selected cases with intractable bleedings unesponsive to conventional replacement therapy.",
keywords = "Bleeding diasthesis, Factor VIIa, Preterm",
author = "Emel Altuncu and Su Berrak and H{\"u}lya Bilgen and Ziya Yurdakul and Cengiz Canpolat and Eren {\"O}zek",
year = "2007",
doi = "10.1080/14767050701411935",
language = "English (US)",
volume = "20",
pages = "627--629",
journal = "Journal of Maternal-Fetal and Neonatal Medicine",
issn = "1476-7058",
publisher = "Informa Healthcare",
number = "8",

}

TY - JOUR

T1 - Use of recombinant factor VIIa in a preterm infant with coagulopathy and subdural hematoma

AU - Altuncu, Emel

AU - Berrak, Su

AU - Bilgen, Hülya

AU - Yurdakul, Ziya

AU - Canpolat, Cengiz

AU - Özek, Eren

PY - 2007

Y1 - 2007

N2 - Activated recombinant factor VIIa was administered to a preterm infant with bleeding diasthesis and a huge subdural hematoma that could not be controlled by the blood products. The coagulation tests were normalized the following day. Recombinant factor VIIa can be a choice in selected cases with intractable bleedings unesponsive to conventional replacement therapy.

AB - Activated recombinant factor VIIa was administered to a preterm infant with bleeding diasthesis and a huge subdural hematoma that could not be controlled by the blood products. The coagulation tests were normalized the following day. Recombinant factor VIIa can be a choice in selected cases with intractable bleedings unesponsive to conventional replacement therapy.

KW - Bleeding diasthesis

KW - Factor VIIa

KW - Preterm

UR - http://www.scopus.com/inward/record.url?scp=34547676266&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34547676266&partnerID=8YFLogxK

U2 - 10.1080/14767050701411935

DO - 10.1080/14767050701411935

M3 - Article

VL - 20

SP - 627

EP - 629

JO - Journal of Maternal-Fetal and Neonatal Medicine

JF - Journal of Maternal-Fetal and Neonatal Medicine

SN - 1476-7058

IS - 8

ER -